Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms

P. Lissoni, S. Barni, G. Tancini, S. Viviani, F. Rovelli, R. Resc aldani, G. Fiorelli

Research output: Contribution to journalArticle

Abstract

The clinical significance of sIL-2R in solid tumors has still to be clarified. To further define the biological role of sIL-2R in cancer and their relation to chemotherapy, we have measured serum levels of sIL-2R and CD4/CD8 ratio in 45 patients with limited or metastatic solid tumor, 28 of whom had never received chemotherapy, whereas the other 17 had been previously treated with chemotherapy. sIL-2R were significantly higher in metastatic cancer patients than in the non-metastatic ones, while no difference was seen between patients treated and untreated with chemotherapy. Within the untreated group, sIL-2R mean values were significantly higher in patients with low CD4/CD8 ratio than in those with the normal one, while an opposite behavior was seen in patients previously treated with chemoterapy. The present study shows that cancer chemotherapy influences the release of sIL-2R and its relation to T lymphocyte subpopulations.

Original languageEnglish
Pages (from-to)131-133
Number of pages3
JournalJournal of Biological Regulators and Homeostatic Agents
Volume3
Issue number3
Publication statusPublished - 1989

Fingerprint

CD4-CD8 Ratio
Interleukin-2 Receptors
interleukin-2
drug therapy
Drug Therapy
receptors
neoplasms
Serum
Neoplasms
Lymphocyte Subsets
T-lymphocytes
T-Lymphocytes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Endocrinology
  • Physiology
  • Immunology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)

Cite this

Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms. / Lissoni, P.; Barni, S.; Tancini, G.; Viviani, S.; Rovelli, F.; Resc aldani, R.; Fiorelli, G.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 3, No. 3, 1989, p. 131-133.

Research output: Contribution to journalArticle

Lissoni, P. ; Barni, S. ; Tancini, G. ; Viviani, S. ; Rovelli, F. ; Resc aldani, R. ; Fiorelli, G. / Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms. In: Journal of Biological Regulators and Homeostatic Agents. 1989 ; Vol. 3, No. 3. pp. 131-133.
@article{d85d8cfcd91d44e8b6201ef16e9b0816,
title = "Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms",
abstract = "The clinical significance of sIL-2R in solid tumors has still to be clarified. To further define the biological role of sIL-2R in cancer and their relation to chemotherapy, we have measured serum levels of sIL-2R and CD4/CD8 ratio in 45 patients with limited or metastatic solid tumor, 28 of whom had never received chemotherapy, whereas the other 17 had been previously treated with chemotherapy. sIL-2R were significantly higher in metastatic cancer patients than in the non-metastatic ones, while no difference was seen between patients treated and untreated with chemotherapy. Within the untreated group, sIL-2R mean values were significantly higher in patients with low CD4/CD8 ratio than in those with the normal one, while an opposite behavior was seen in patients previously treated with chemoterapy. The present study shows that cancer chemotherapy influences the release of sIL-2R and its relation to T lymphocyte subpopulations.",
author = "P. Lissoni and S. Barni and G. Tancini and S. Viviani and F. Rovelli and {Resc aldani}, R. and G. Fiorelli",
year = "1989",
language = "English",
volume = "3",
pages = "131--133",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "3",

}

TY - JOUR

T1 - Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms

AU - Lissoni, P.

AU - Barni, S.

AU - Tancini, G.

AU - Viviani, S.

AU - Rovelli, F.

AU - Resc aldani, R.

AU - Fiorelli, G.

PY - 1989

Y1 - 1989

N2 - The clinical significance of sIL-2R in solid tumors has still to be clarified. To further define the biological role of sIL-2R in cancer and their relation to chemotherapy, we have measured serum levels of sIL-2R and CD4/CD8 ratio in 45 patients with limited or metastatic solid tumor, 28 of whom had never received chemotherapy, whereas the other 17 had been previously treated with chemotherapy. sIL-2R were significantly higher in metastatic cancer patients than in the non-metastatic ones, while no difference was seen between patients treated and untreated with chemotherapy. Within the untreated group, sIL-2R mean values were significantly higher in patients with low CD4/CD8 ratio than in those with the normal one, while an opposite behavior was seen in patients previously treated with chemoterapy. The present study shows that cancer chemotherapy influences the release of sIL-2R and its relation to T lymphocyte subpopulations.

AB - The clinical significance of sIL-2R in solid tumors has still to be clarified. To further define the biological role of sIL-2R in cancer and their relation to chemotherapy, we have measured serum levels of sIL-2R and CD4/CD8 ratio in 45 patients with limited or metastatic solid tumor, 28 of whom had never received chemotherapy, whereas the other 17 had been previously treated with chemotherapy. sIL-2R were significantly higher in metastatic cancer patients than in the non-metastatic ones, while no difference was seen between patients treated and untreated with chemotherapy. Within the untreated group, sIL-2R mean values were significantly higher in patients with low CD4/CD8 ratio than in those with the normal one, while an opposite behavior was seen in patients previously treated with chemoterapy. The present study shows that cancer chemotherapy influences the release of sIL-2R and its relation to T lymphocyte subpopulations.

UR - http://www.scopus.com/inward/record.url?scp=0024784465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024784465&partnerID=8YFLogxK

M3 - Article

C2 - 2560317

AN - SCOPUS:0024784465

VL - 3

SP - 131

EP - 133

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 3

ER -